You are here
APHIOS CORPORATION
UEI: HDE2J1H521A7
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Alzheimer's Disease Therapeutic
Amount: $263,690.00DESCRIPTION (provided by applicant): Alzheimer's Disease (AD) is a significant neurological disorder that afflicts more than 4.5 million Americans and more than 10 million people worldwide. The lack o ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
CFI Inactivation of Human Plasma
Amount: $344,267.00DESCRIPTION (provided by applicant): The worldwide AIDS epidemic, the periodic emergence of Ebola and SARS, and the recent outbreaks of potentially pandemic strains of influenza such as H5N1 have high ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
D9-THC for Marijuana Addiction
Amount: $109,761.00DESCRIPTION (provided by applicant): ?9-tetrahydrocannabinol (?9-THC) has been shown to alleviate marijuana withdrawal symptoms and thus has potential for treating cannabinoid dependence. However, the ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
402- RFP: N43-CM-87007-68 TOPIC 251: DEVELOPMENT OF ANTICANCER AGENTS REQUEST
Amount: $149,558.00The aim of this project is the development of Tyrosyl DNA phosphodiesterase (Tdp1) inhibitors in order to enhance the activity of DNA topoisomerase I inhibitors.
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Alkylating Vitamin D Derivative
Amount: $258,398.00DESCRIPTION (provided by applicant): Prostate cancer is the most prevalent cancer among men; and the second leading cause of cancer death among men in the US. There are currently no approved therapies ...
STTRPhase I2007Department of Health and Human Services National Institutes of Health -
BIODEGRADABLE POLYMER ENCAPSULATED NANOPARTICLES FOR ORA
Amount: $99,986.00N/A
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
Development of Novel Anti-HIV Therapeutics
Amount: $898,408.00DESCRIPTION (provided by applicant): Currently, there are 42 million AIDS cases worldwide, with a majority present in the third world; 3.1 million deaths can be attributed to HIV and AIDS in 2002 alo ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Anti-Smallpox Therapeutics from Marine Micoorganisms
Amount: $264,705.00DESCRIPTION (provided by investigator): The terrorist events of September 11th and the recent criminal anthrax exposures have increased awareness of the use of smallpox as a biological weapon. A short ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
Development of Novel Anti-Influenza Agents
Amount: $305,212.00DESCRIPTION (provided by applicant): Influenza is a common and serious respiratory illness affecting tens of thousands each year and causing 20,000 - 40,000 deaths. This significantly contributes to ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
SUPERFLUIDS ISOLATION OF NATURAL ANTI-CANCER DRUGS
Amount: $750,000.00N/A
SBIRPhase II2002Department of Health and Human Services National Institutes of Health
